$Pfizer(PFE)$ It's going to be

It's going to be well worth the wait to see Wall Street recognize the extreme value of the Seagen acquisition. That deal has NOTHING to do with the current sales derived from the acquisition, which will be around $3 billion in 2024. It has EVERYTHING to do with the ability to create more derivatives of these meds and using them in combination with current and future cancer therapies to GREATLY advance the fight. There will be a multitude of new drugs that Pfizer will develop and launch as a result of this combination, and they will be far superior as well. This will be a massive opportunity that Pfizer will realize down the road. Until then buy and accumulate during this down era before Wall Street finally wakes up.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":269089925431304,"tweetId":"269089925431304","gmtCreate":1706720394507,"gmtModify":1706720397316,"author":{"id":9000000000000582,"idStr":"9000000000000582","authorId":9000000000000582,"authorIdStr":"9000000000000582","name":"GabrielleSusan","avatar":"https://static.tigerbbs.com/765c9daae36bd47c3c2192e4245c8d47","vip":8,"userType":8,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":21,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"html":"<html><head></head><body> <a data-mention-id=\"PFE\" class=\"teditor-mention\" data-mention-name=\"Pfizer\" href=\"https://ttm.financial/S/PFE\">$Pfizer(PFE)$</a> <v-v data-views=\"1\"></v-v>It's going to be well worth the wait to see Wall Street recognize the extreme value of the Seagen acquisition. That deal has NOTHING to do with the current sales derived from the acquisition, which will be around $3 billion in 2024. It has EVERYTHING to do with the ability to create more derivatives of these meds and using them in combination with current and future cancer therapies to GREATLY advance the fight. There will be a multitude of new drugs that Pfizer will develop and launch as a result of this combination, and they will be far superior as well. This will be a massive opportunity that Pfizer will realize down the road. Until then buy and accumulate during this down era before Wall Street finally wakes up.</body></html>","htmlText":"<html><head></head><body> <a data-mention-id=\"PFE\" class=\"teditor-mention\" data-mention-name=\"Pfizer\" href=\"https://ttm.financial/S/PFE\">$Pfizer(PFE)$</a> <v-v data-views=\"1\"></v-v>It's going to be well worth the wait to see Wall Street recognize the extreme value of the Seagen acquisition. That deal has NOTHING to do with the current sales derived from the acquisition, which will be around $3 billion in 2024. It has EVERYTHING to do with the ability to create more derivatives of these meds and using them in combination with current and future cancer therapies to GREATLY advance the fight. There will be a multitude of new drugs that Pfizer will develop and launch as a result of this combination, and they will be far superior as well. This will be a massive opportunity that Pfizer will realize down the road. Until then buy and accumulate during this down era before Wall Street finally wakes up.</body></html>","text":"$Pfizer(PFE)$ It's going to be well worth the wait to see Wall Street recognize the extreme value of the Seagen acquisition. That deal has NOTHING to do with the current sales derived from the acquisition, which will be around $3 billion in 2024. It has EVERYTHING to do with the ability to create more derivatives of these meds and using them in combination with current and future cancer therapies to GREATLY advance the fight. There will be a multitude of new drugs that Pfizer will develop and launch as a result of this combination, and they will be far superior as well. This will be a massive opportunity that Pfizer will realize down the road. Until then buy and accumulate during this down era before Wall Street finally wakes up.","highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://ttm.financial/post/269089925431304","repostId":0,"isVote":1,"tweetType":1,"viewCount":319,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["PFE"],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":610,"xxTargetLangEnum":"ORIG"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/269089925431304"}